Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Insulin Lantus
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lantus 100units/ml inj 3ml pre-filled SoloStar pens
0601012V0BBAEAD
|
Insulin Lantus | Insulin glargine | Endocrine System | 183,126 |
|
Lantus 100units/ml solution for injection 3ml cartridges
0601012V0BBAAAA
|
Insulin Lantus | Insulin glargine | Endocrine System | 34,860 |
|
Lantus 100units/ml solution for injection 10ml vials
0601012V0BBABAB
|
Insulin Lantus | Insulin glargine | Endocrine System | 2,207 |
|
Lantus 100units/ml inj 3ml OptiClik cartridges
0601012V0BBADAA
|
Insulin Lantus | Insulin glargine | Endocrine System | No data available |
|
Lantus 100units/ml inj 3ml pre-filled OptiSet pens
0601012V0BBACAD
|
Insulin Lantus | Insulin glargine | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.